Department of Pharmacology, Centre of Excellence for Translational Medicine, University of Tartu, Ravila 19, Tartu EE-51014, Estonia.
J Cell Sci. 2012 Feb 1;125(Pt 3):625-33. doi: 10.1242/jcs.090126. Epub 2012 Feb 13.
Calcium pumping into the endoplasmic reticulum (ER) lumen is thought to be coupled to a countertransport of protons through sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) and the members of the ClC family of chloride channels. However, pH in the ER lumen remains neutral, which suggests a mechanism responsible for proton re-entry. We studied whether cation-proton exchangers could act as routes for such a re-entry. ER Ca(2+) uptake was measured in permeabilized immortalized hypothalamic neurons, primary rat cortical neurons and mouse cardiac fibers. Replacement of K(+) in the uptake solution with Na(+) or tetraethylammonium led to a strong inhibition of Ca(2+) uptake in neurons and cardiomyocytes. Furthermore, inhibitors of the potassium-proton exchanger (quinine or propranolol) but not of the sodium-proton exchanger reduced ER Ca(2+) uptake by 56-82%. Externally added nigericin, a potassium-proton exchanger, attenuated the inhibitory effect of propranolol. Inhibitors of small conductance calcium-sensitive K(+) (SK(Ca)) channels (UCL 1684, dequalinium) blocked the uptake of Ca(2+) by the ER in all preparations by 48-94%, whereas inhibitors of other K(+) channels (IK(Ca), BK(Ca) and K(ATP)) had no effect. Fluorescence microscopy and western blot analysis revealed the presence of both SK(Ca) channels and the potassium-proton exchanger leucine zipper-EF-hand-containing transmembrane protein 1 (LETM1) in ER in situ and in the purified ER fraction. The data obtained demonstrate that SK(Ca) channels and LETM1 reside in the ER membrane and that their activity is essential for ER Ca(2+) uptake.
内质网(ER)腔中的钙泵入被认为与通过肌浆/内质网钙 ATP 酶(SERCA)和氯离子通道 ClC 家族成员的质子反向转运相关。然而,ER 腔中的 pH 值保持中性,这表明存在负责质子再进入的机制。我们研究了阳离子-质子交换器是否可以作为这种再进入的途径。在透化的永生下丘脑神经元、原代大鼠皮质神经元和小鼠心肌纤维中测量 ER Ca2+摄取。在摄取溶液中用 Na+或四乙铵替代 K+会强烈抑制神经元和心肌细胞中的 Ca2+摄取。此外,钾-质子交换器抑制剂(奎宁或普萘洛尔)而不是钠-质子交换器抑制剂将 ER Ca2+摄取减少了 56-82%。外加的钾-质子交换器 Nigericin 减弱了普萘洛尔的抑制作用。小电导钙敏钾(SK(Ca)) 通道抑制剂 (UCL 1684、地喹氯铵) 使所有制剂中的 ER Ca2+摄取分别减少了 48-94%,而其他钾通道(IK(Ca)、BK(Ca) 和 K(ATP)) 抑制剂则没有作用。荧光显微镜和 Western blot 分析显示,SK(Ca) 通道和钾-质子交换器亮氨酸拉链 EF 手跨膜蛋白 1 (LETM1) 都存在于原位 ER 和纯化的 ER 级分中。获得的数据表明,SK(Ca) 通道和 LETM1 存在于 ER 膜中,其活性对于 ER Ca2+摄取是必需的。